LGND Operating Cash Flow

Ligand Pharmaceuticals Inc · Operating Cash Flow

LGND logo

LGND Operating Cash Flow

Latest reported$131.64M
LGND TTM Operating Cash Flow (-$14.30M → $131.64M)
High-resolution chart · PNG

LGND operating cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Operating Cash Flow — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (USD)
131,643,000
123,422,000
49,215,000
31,842,000
55,282,000
52,799,000
97,006,000
75,651,000
46,767,000
33,371,000
48,628,000
94,984,000
107,827,000
119,787,000
137,850,000
112,020,000
111,556,000
120,055,000
78,798,000
51,693,000
44,413,000
48,418,000
54,586,000
46,710,000
27,768,000
-57,672,000
-29,336,000
10,575,000
43,854,000
178,556,000
194,059,000
192,797,000
193,365,000
130,107,000
93,568,000
83,251,000
74,124,000
74,109,000
63,001,000
55,673,000
47,587,000
47,262,000
41,727,000
38,308,000
31,606,000
25,568,000
20,566,000
22,354,000
18,260,000
21,189,000
20,690,000
10,828,000
10,277,000
2,608,000
161,000
5,006,000
4,861,000
-2,452,000
-1,172,000
-9,489,000
-16,108,000
-10,280,000
-27,067,000
-27,056,000
-30,723,000
-25,556,000
-33,801,000
-26,319,000
-28,426,000
-35,347,000
-20,625,000
-35,605,000
-36,388,000
-61,777,000
-97,727,000
-173,009,000
-186,799,000
-163,886,000
-138,521,000
-42,380,000
-7,564,000
-9,022,000
8,365,000
24,333,000
10,504,000
6,773,000
5,754,000
-13,110,000
-8,687,000
6,405,000
274,000
-18,464,000
-19,379,000
-34,718,000
-25,112,000
-19,021,000
-22,451,000
-6,905,000
-19,906,000
-25,585,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.